ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
42 announcements with these filters
Arvaya Healthcare Limited received BSE approval to reclassify four promoter group members as public shareholders. The outgoing promoters held 0% shares.
Arvaya Healthcare Limited issued a corrigendum to correct EPS errors in its FY26 financial results. The update ensures accurate reporting of earnings data for investors.
Arvaya Healthcare Limited exceeded SEBI LODR exemption thresholds on March 4, 2026. The company will now comply with applicable corporate governance and secretarial reporting norms.
Bijoy Hans Ltd reported revenue from operations of ₹9.1 Cr and net profit of ₹1.5 Cr for Q4 FY26.
Arvaya Healthcare Limited reported audited financial results for the fiscal year ended March 31, 2026. The company also announced the appointment of new internal auditors.
Arvaya Healthcare Limited scheduled a board meeting for May 28, 2026. Directors will consider and approve audited financial statements for the fiscal year ended March 2026.
Bijoy Hans Limited has officially changed its name to Arvaya Healthcare Limited following MCA approval. The amendment to its Memorandum and Articles of Association is effective immediately.
Bijoy Hans Ltd has designated its Audit Committee as the primary body for 'Those Charged with Governance' (TCWG) per NFRA guidelines. The Board also appointed CFO Mr. Ranganath Abhiram as Nodal Officer and adopted a two-way communication framework policy with statutory auditors. These steps aim to strengthen audit-related communications and corporate governance compliance.
Bijoy Hans Ltd has received trading approval from BSE for 4,05,21,836 equity shares issued on a preferential basis to promoters and non-promoters. The approval, dated April 22, 2026, makes these shares effective for trading from April 23, 2026.
Bijoy Hans Limited announced the results of its postal ballot where nine resolutions were passed with the requisite majority. Key resolutions included a name change to Arvaya Healthcare Limited, increasing borrowing limits, and revising director remuneration. All eight special resolutions and one ordinary resolution were successfully approved by shareholders.
Bijoy Hans Limited received BSE listing approval for 4,05,21,836 equity shares issued on a preferential basis at Rs. 12.50 per share, totaling ₹50.65 Crore. The shares were allotted to both promoters and non-promoters.
Bijoy Hans Ltd reported a net loss of ₹0.2 Cr for Q3 FY26.